标题
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic
作者
关键词
-
出版物
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-10-20
DOI
10.1016/j.tips.2022.09.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders
- (2022) Chad R. Johnson et al. Biomedicines
- Role of Cholinergic Signaling in Alzheimer’s Disease
- (2022) Zhi-Ru Chen et al. MOLECULES
- Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics
- (2022) Daisy L. Spark et al. Translational Psychiatry
- Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
- (2022) Steven M. Paul et al. AMERICAN JOURNAL OF PSYCHIATRY
- Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
- (2021) Stephen K. Brannan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting muscarinic receptors to treat schizophrenia
- (2021) Daniel J. Foster et al. BEHAVIOURAL BRAIN RESEARCH
- Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
- (2021) Srijan Acharya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
- (2021) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders
- (2021) Lauren A. Poppi et al. Cells
- Functionally selective and biased agonists of muscarinic receptors
- (2021) Alena Randáková et al. PHARMACOLOGICAL RESEARCH
- Modulation of motor behavior by the mesencephalic locomotor region
- (2021) Daniel Dautan et al. Cell Reports
- From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease
- (2021) Alastair J.H. Brown et al. CELL
- Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkey
- (2021) Henry S. Lange et al. NEUROPHARMACOLOGY
- New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
- (2021) Maria C. Lobo et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- New Antipsychotic Medications in the Last Decade
- (2021) Mehak Pahwa et al. Current Psychiatry Reports
- M 1 muscarinic receptor activation decreases alcohol consumption via a reduction in consummatory behavior
- (2021) Leigh C. Walker et al. Pharmacology Research & Perspectives
- An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease
- (2020) Andrea Haake et al. Expert Opinion On Drug Safety
- Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs
- (2020) Sophie J. Bradley et al. Nature Chemical Biology
- Priming of GABAergic Long-term Potentiation by Muscarinic Receptors
- (2020) Koyam Morales-Weil et al. NEUROSCIENCE
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
- (2020) Oliwia Koszła et al. Biomolecules
- Muscarinic Receptors, from Synaptic Plasticity to its Role in Network Activity
- (2020) D. Fernández de Sevilla et al. NEUROSCIENCE
- Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies
- (2020) Daniel Dautan et al. Nature Communications
- Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia
- (2020) Brian Dean et al. PSYCHIATRY RESEARCH
- Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
- (2020) Susan F. Sonnenschein et al. Frontiers in Psychiatry
- M1 muscarinic acetylcholine receptor‐mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons
- (2020) Etsuko Suzuki et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain
- (2020) Caterina Montani et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate Hypothesis in Schizophrenia
- (2019) Yota Uno et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys
- (2019) Emi Kurimoto et al. PLoS One
- T119. Differences in Nucleus Accumbens Dopamine Release via Muscarinic Acetylcholine Receptor Subtypes: Implications for Manifestation of Negative Symptoms
- (2019) Samantha Yohn et al. BIOLOGICAL PSYCHIATRY
- NMDAR Hypofunction Animal Models of Schizophrenia
- (2019) Gloria Lee et al. Frontiers in Molecular Neuroscience
- Widespread changes in positive allosteric modulation of the muscarinic M1 receptor in some subjects with schizophrenia
- (2019) Shaun Hopper et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate
- (2019) A.J. Robison et al. BIOLOGICAL PSYCHIATRY
- Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
- (2019) Oliver D. Howes et al. NEUROPSYCHOPHARMACOLOGY
- Role of laterodorsal tegmentum projections to nucleus accumbens in reward-related behaviors
- (2019) Bárbara Coimbra et al. Nature Communications
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
- (2019) Sean P. Moran et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Biased G Protein–Coupled Receptor Signaling
- (2018) James W. Wisler et al. CIRCULATION
- Bitopic Binding Mode of an M1Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes
- (2018) Sophie J. Bradley et al. MOLECULAR PHARMACOLOGY
- Positive allosteric modulation of M 1 and M 4 muscarinic receptors as potential therapeutic treatments for schizophrenia
- (2018) Samantha E. Yohn et al. NEUROPHARMACOLOGY
- Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases
- (2018) Christian C. Felder et al. NEUROPHARMACOLOGY
- Simultaneous activation of muscarinic and GABAB receptors as a bidirectional target for novel antipsychotic
- (2018) Paulina Cieślik et al. BEHAVIOURAL BRAIN RESEARCH
- Low levels of muscarinic M1 receptor–positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia
- (2018) Elizabeth Scarr et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
- (2018) Frederick C. Nucifora et al. NEUROBIOLOGY OF DISEASE
- Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
- (2017) Robert McCutcheon et al. SCHIZOPHRENIA BULLETIN
- Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
- (2016) Jennifer E. Davoren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
- (2016) David M. Thal et al. NATURE
- Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways
- (2016) Cheng Xiao et al. NEURON
- Antipsychotic-like Effects of M 4 Positive Allosteric Modulators Are Mediated by CB 2 Receptor-Dependent Inhibition of Dopamine Release
- (2016) Daniel J. Foster et al. NEURON
- State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 – Relation to antipsychotic-like drug effects
- (2016) Robert W. Gould et al. NEUROPHARMACOLOGY
- Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions
- (2015) Kalynda K. Gonzales et al. Annals of the New York Academy of Sciences
- Muscarinic presynaptic modulation in GABAergic pallidal synapses of the rat
- (2015) Ricardo Hernández-Martínez et al. JOURNAL OF NEUROPHYSIOLOGY
- Direct excitation of parvalbumin-positive interneurons by M1muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition
- (2014) Feng Yi et al. JOURNAL OF PHYSIOLOGY-LONDON
- Animal models for predicting the efficacy and side effects of antipsychotic drugs
- (2014) Pedro H. Gobira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine
- (2012) Ditte Dencker et al. PSYCHOPHARMACOLOGY
- M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition
- (2012) Hisatsugu Koshimizu et al. Molecular Brain
- Striatal Muscarinic Receptors Promote Activity Dependence of Dopamine Transmission via Distinct Receptor Subtypes on Cholinergic Interneurons in Ventral versus Dorsal Striatum
- (2010) S. Threlfell et al. JOURNAL OF NEUROSCIENCE
- Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice
- (2009) Yoshihiko Ito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antipsychotic-induced movement disorders – forgotten but not gone
- (2008) Peter J. Weiden ACTA PSYCHIATRICA SCANDINAVICA
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
- (2008) C. K. Jones et al. JOURNAL OF NEUROSCIENCE
- In Vivo Activation of Midbrain Dopamine Neurons via Sensitized, High-Affinity α6∗ Nicotinic Acetylcholine Receptors
- (2008) Ryan M. Drenan et al. NEURON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now